Finance

Lists
300583:SHE
Shandong Sito Bio-technology Co Ltd
CNÂ¥13.80
+3.22%
(+0.43) 1D
Sep 8, 3:04:43 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300583...
Open
CNÂ¥13.43
High
CNÂ¥13.87
Low
CNÂ¥13.33
Mkt. cap
2.57B
Avg. vol.
4.40M
Volume
6.42M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 14, 2026
P/E ratio
268.07
52-wk high
CNÂ¥16.60
52-wk low
CNÂ¥10.63
EPS
CNÂ¥0.05
Shares outstanding
189.70M
No. of employees
990
Open
CNÂ¥13.43
High
CNÂ¥13.87
Low
CNÂ¥13.33
Mkt. cap
2.57B
Avg. vol.
4.40M
Volume
6.42M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 14, 2026
P/E ratio
268.07
52-wk high
CNÂ¥16.60
52-wk low
CNÂ¥10.63
EPS
CNÂ¥0.05
Shares outstanding
189.70M
No. of employees
990
About Shandong Sito Bio-technology Co Ltd
CEO-
Employees990
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
241.43M
267.68M
328.05M
284.69M
Cost of goods sold
184.84M
245.33M
255.61M
201.29M
Cost of revenue
184.84M
245.33M
255.61M
201.29M
Research and development expenses
9.79M
9.29M
10.11M
11.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.96M
28.26M
39.48M
28.90M
Operating expense
38.32M
37.45M
55.97M
39.33M
Total operating expenses
223.17M
282.78M
311.59M
240.62M
Operating income
18.26M
-15.10M
16.46M
44.07M
Other non operating income
805.63K
-3.36M
-2.78M
-15.94M
EBT including unusual items
-17.69M
-1.86M
6.46M
34.10M
EBT excluding unusual items
15.39M
-25.68M
9.20M
35.90M
Income tax expense
1.60M
3.69M
1.89M
7.71M
Effective tax rate
-9.04%
-197.99%
29.20%
22.62%
Other operating expenses
-3.66M
6.35M
2.97M
2.45M
Net income
-16.54M
-3.92M
3.62M
26.61M
Net profit margin
-6.85%
-1.46%
1.10%
9.35%
Earnings per share
-
-
-
-
Interest and investment income
1.66M
1.36M
385.18K
10.27M
Interest expense
-6.27M
-7.25M
-7.36M
-
Net interest expenses
-4.61M
-5.89M
-6.98M
10.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.69M
26.17M
57.73M
86.02M
Gain or loss from assets sale
-162.58K
824.30K
-
-217.91K
AI content may include mistakes. Learn more
Google apps